Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.

Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.

Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...

Podrobná bibliografie
Hlavní autoři:	Mukhtyar, C, Luqmani, R
Médium:	Journal article
Jazyk:	English
Vydáno:	2007

Podobné jednotky

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
Autor: Mukhtyar, C, a další
Vydáno: (2008)

Eular recommendations for vasculitis
Autor: Luqmani, R, a další
Vydáno: (2007)

Cardiovascular outcomes in ANCA associated vasculitis
Autor: Mukhtyar, C, a další
Vydáno: (2008)

Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
Autor: Mukhtyar, C, a další
Vydáno: (2007)

Cardiovascular involvement in primary systemic vasculitis.
Autor: Mukhtyar, C, a další
Vydáno: (2009)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
Autor: Luqmani, R, a další
Vydáno: (2009)

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (VERSION 3) FOR DIAGNOSING VASCULITIS
Autor: Mukhtyar, C, a další
Vydáno: (2009)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
Autor: Mukhtyar, C, a další
Vydáno: (2008)

Outpatient assessment of systemic vasculitis.
Autor: Nataraja, A, a další
Vydáno: (2007)

Outcome measures in ANCA-associated vasculitis.
Autor: Suppiah, R, a další
Vydáno: (2010)

The role of biologic therapies in the management of systemic vasculitis.
Autor: Chan, A, a další
Vydáno: (2006)

Current evidence of factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis. A systematic review for the EULAR systemic vasculitis task force
Autor: Mukhtyar, C, a další
Vydáno: (2007)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Autor: Mukhtyar, C, a další
Vydáno: (2006)

The vasculitis damage index as a surrogate outcome measure in systemic vasculitis.
Autor: McRorie, E, a další
Vydáno: (1997)

Outcome in systemic vasculitis.
Autor: Luqmani, R, a další
Vydáno: (1998)

Factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis
Autor: Luqmani, R, a další
Vydáno: (2007)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
Autor: Walsh, M, a další
Vydáno: (2011)

Validation of the Birmingham Vasculitis Activity Score (Version 3)
Autor: Mukhtyar, C, a další
Vydáno: (2009)

Disease assessment in systemic vasculitis
Autor: Luqmani, R
Vydáno: (2004)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
Autor: Suppiah, R, a další
Vydáno: (2011)

Outcome in small-vessel systemic vasculitis.
Autor: Luqmani, R, a další
Vydáno: (2006)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
Autor: Robson, J, a další
Vydáno: (2018)

Evaluation of vasculitis disease activity in Europe.
Autor: Luqmani, R
Vydáno: (2001)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
Autor: Robson JC, a další
Vydáno: (2018-01-01)

Current status of outcome measure development in vasculitis.
Autor: Merkel, P, a další
Vydáno: (2014)

Validation of a new version of the Birmingbam vasculitis activity score
Autor: Mukhtyar, C, a další
Vydáno: (2008)

Vasculitis: an update.
Autor: Luqmani, R
Vydáno: (2014)

Vasculitis: an update.
Autor: Luqmani, R
Vydáno: (2014)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
Autor: Robson, J, a další
Vydáno: (2017)

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index.
Autor: Suppiah, R, a další
Vydáno: (2011)

Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
Autor: Suppiah, R, a další
Vydáno: (2010)

Discontinuation of therapies in vasculitis.
Autor: Luqmani, R
Vydáno: (2013)

Discontinuation of therapies in vasculitis.
Autor: Luqmani, R
Vydáno: (2013)

Discontinuation of therapies in vasculitis.
Autor: Luqmani, R
Vydáno: (2013)

CLASSIFICATION AND DIAGNOSIS OF VASCULITIS
Autor: Luqmani, R
Vydáno: (2012)

A disease-specific patient-reported outcome for ANCA associated vasculitis: scale structure and measurement properties of the AAV- PRO
Autor: Robson, J, a další
Vydáno: (2017)

Pharmacotherapy of vasculitis.
Autor: Chan, M, a další
Vydáno: (2009)

Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Autor: Robson, J, a další
Vydáno: (2016)

MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA)
Autor: Suppiah, R, a další
Vydáno: (2010)

276 The short-term damage burden in vasculitis and vasculitis mimics as measured by the vasculitis damage index
Autor: Floris, A, a další
Vydáno: (2016)